Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pulmonary Embolism Accurately Predicted by Clinical Model

By HospiMedica International staff writers
Posted on 01 Oct 2008
A software algorithm model based on clinical symptoms, signs, and electrocardiogram (ECG) interpretation can accurately predict pulmonary embolism (PE).

Researchers at the University of Florence (Florence, Italy) generated the model by analyzing data from 1,100 patients with suspected PE, including 440 patients who had subsequently confirmed cases based on angiography or autopsy findings. More...
The model was then validated in a separate cohort of 400 patients with suspected PE, of whom 71% were inpatients. The validation sample found that 165 (41%) of the 400 patients had PE, which was confirmed by angiography.

The researchers identified a total of 16 variables, of which 10 (older age, male sex, prolonged immobilization, history of deep vein thrombosis, sudden-onset dyspnea, chest pain, syncope, hemoptysis, unilateral leg swelling, ECG signs of acute cor-pulmonale) were positively associated with PE, and six (prior cardiovascular or pulmonary disease, orthopnea, high fever, wheezes, or crackles on chest auscultation) were negatively associated with PE. The prevalence of PE was then calculated in four probability categories. When the researchers' model indicated a slight, moderate, substantial, or high probability of pulmonary embolism, the true rates were 2%, 28%, 67%, and 94%, respectively. There was no significant difference between inpatients and outpatients with respect to the prevalence of pulmonary embolism. The study was published in the August 1, 2008, issue of in the American Journal of Respiratory and Critical Care Medicine.

"The model proposed may provide physicians with a diagnostic edge when evaluating patients for suspected pulmonary embolism,” concluded lead author Massimo Miniati, M.D., and colleagues. "Even though its predictive accuracy is supported by internal and external validation procedures, further validation in patients from other centers would be desirable.”

Pulmonary embolism is a blockage of the pulmonary artery or one of its branches, usually occurring when a blood clot becomes dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs. Symptoms may include difficulty breathing, chest pain during breathing, and in more severe cases, collapse, circulatory instability, and sudden death. Treatment is usually with anticoagulant medication, such as heparin and warfarin, and in severe cases, thrombolysis or surgery.

Related Links:
University of Florence

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.